Pent-Up Demand As GW Pharma’s Epidyolex Approved In Europe

 
• By Andrew McConaghie
  
CBD
Epidyolex meets demand in hard-to-treat epilepsy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip